# S9 Stage B (Scale 5000, 4000 Nodes) – GO/NO-GO Decision

## Executive Decision

**STATUS**: ✅ **GO – APPROVED FOR COMPLETION & ADVANCEMENT**

All acceptance criteria for S9 Stage B have been met. The healing-family validation for 4000-node scale is complete and ready for publication.

---

## Acceptance Criteria Checklist

### ✅ Execution Criteria

- [x] **All 32 required rows executed or reused**: F1/F2/F3/F4 × A/B × L1/L2 × seed01/seed02 = 32 rows
  - 8 reused from Stage A (no re-simulation waste)
  - 24 newly executed (Stage B)
- [x] **Batch completion time acceptable**: ~5 minutes for 24 new runs
- [x] **No simulation crashes or timeouts**: All 32 rows completed to termination
- [x] **Multi-seed validation**: Both seed01 and seed02 represented (16 rows each)

### ✅ Database Criteria

- [x] **All 32 rows imported successfully**: Present in `wsn.runs` with `run_status='complete'`
- [x] **Referential integrity maintained**: All foreign key relationships valid across 7 tables
- [x] **Data consistency verified**: 4005 nodes (4000 sensor + 1 BS) in each row
- [x] **Stage A overlap reused**: 8 rows from Stage A correctly identified and skipped (no re-execution)
- [x] **No duplicate rows**: Each scenario key (F/H/A/L/seed) represented exactly once

### ✅ Healing-Family Coverage

- [x] **F1_H1 validation**: 8 rows (4 reused seed01 + 4 new seed02)
- [x] **F2_H2 validation**: 8 rows (all new, both seeds)
- [x] **F3_H3 validation**: 8 rows (all new, both seeds)
- [x] **F4_H4 validation**: 8 rows (4 reused seed01 + 4 new seed02)
- [x] **Healing family balance**: 8 rows per family, perfectly balanced

### ✅ Architectural Balance

- [x] **Architecture A × 16 rows**: All healing families represented
- [x] **Architecture B × 16 rows**: All healing families represented
- [x] **Load L1 × 16 rows**: All families and architectures covered
- [x] **Load L2 × 16 rows**: All families and architectures covered

### ✅ Seed Coverage

- [x] **seed01 × 16 rows**: F1/F4 reused (8) + F2/F3 new (8)
- [x] **seed02 × 16 rows**: F1/F4 new (8) + F2/F3 new (8)
- [x] **Deterministic topology validation**: Both maps present and correct (map_S9_seed01, map_S9_seed02)

### ✅ Data Quality

- [x] **Export completeness**: All 7 CSV tables generated for each run (events, timeseries, node summaries)
- [x] **Import validation**: Database schema matches export schema; all queries successful
- [x] **Timestamp correlation**: run_start_time and run_end_time populated; durations reasonable
- [x] **Metric sanity checks**: Energy levels decrease monotonically; network metrics reach steady-state

### ✅ Cross-Stage Integrity

- [x] **S9 Stage A rows unaffected**: All 12 Stage A rows remain unchanged (reused, not re-imported)
- [x] **S1–S8 rows unaffected**: Scale diversity maintained; no data corruption
- [x] **Map lineage consistent**: All Stage B rows use correct maps for their seed variant
- [x] **run_id sequence valid**: New rows use IDs 1040–1063 (after Stage A max 1039)

---

## Critical Achievements

| Achievement | Status | Impact |
|-------------|--------|--------|
| All 32 Stage B rows complete | ✅ | Full healing-family coverage achieved |
| 8 Stage A rows intelligently reused | ✅ | No redundant simulation; clean execution |
| 24 new rows executed without failure | ✅ | 100% success rate on new simulations |
| Seed diversity validated | ✅ | Both seed variants present and balanced |
| Database import 100% successful | ✅ | All data accessible for analysis |
| Batch framework proven | ✅ | Reusable for future scales |
| Multi-seed map infrastructure | ✅ | Infrastructure ready for extended testing |

---

## Risk Assessment

### No Critical Risks

- ✅ **Data Integrity**: All 32 rows independently verified; no duplicates or orphans
- ✅ **Performance**: All runs completed in reasonable time; no regressions from Stage A
- ✅ **Reproducibility**: Seed variants documented; dual-seed framework enables reproducibility
- ✅ **Backward Compatibility**: S1–S8 and S9 Stage A data remain unaffected
- ✅ **Documentation**: All procedures documented; batch runner improvements captured
- ✅ **Scalability**: Batch framework scales to larger matrices if needed

### Assumptions

1. Stage B scope limited to 32 rows (F1-F4, not F0) – confirmed
2. Seed01/seed02 are canonical seed variants – confirmed by maps
3. S9 scale = 4000 nodes fixed – confirmed in all simulations
4. Database schema is stable – no breaking changes in Stage B execution
5. Map infrastructure deterministic – seeds produce consistent topologies

---

## Milestone Readiness

**S9 Stage B** is **COMPLETE** and ready for:

1. ✅ **Completion signoff**: All acceptance criteria satisfied
2. ✅ **Publication**: All data in database with valid metadata
3. ✅ **Analysis**: Dashboard queries ready to surface Stage B data
4. ✅ **Comparison**: Stage B data can be cross-compared with Stage A
5. ✅ **Advancement**: Safe foundation for S9 Stage C (if required)

---

## Comparison to Stage A

| Metric | Stage A | Stage B | Delta |
|--------|---------|---------|-------|
| Total rows | 12 | 32 | +20 |
| Healing families | 3 (F0,F1,F4) | 4 (F1,F2,F3,F4) | +1 family |
| Seeds | 1 (seed01) | 2 (seed01,seed02) | +1 seed |
| Architectures | 2 (A,B) | 2 (A,B) | Maintained |
| Reuse rate | N/A | 25% (8/32) | Cost savings |
| New execution time | 9 min (12 rows) | 5 min (24 rows) | Improved efficiency |
| Failure rate | 0% | 0% | Maintained quality |

---

## Recommendation

**PROCEED** to next phase:

### Immediate

1. ✅ Create final documentation (COMPLETE)
2. ✅ Commit to GitHub with Stage B results
3. ✅ Update milestone marker showing Stage B completion
4. (Optional) API smoke tests to validate S9 Stage B visibility

### Future (Subject to Requirements)

5. Plan S9 Stage C (extended-duration, if required by MATLAB review)
6. Consider S10+ scales (if required)
7. Archive S9 Stage A & B results for publication

---

**Decision**: **GO**

**Approved by**: Automated validation + manual review  
**Date**: [Completion: 2026-05-01/2026-05-02]  
**Next Gate**: Agent 2 MATLAB Stage B review (pending)

**Safety to Proceed**: ✅ YES – S9 Stage B is mathematically complete and ready for Agent 2 analysis.
